10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2022-05-16 (Q1 2022) | Holdings: 96 | Value: $4.6B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S | 19.38% | $888.2M | +106.31% | +12.47% | +5.28% | ||
| BIIB - BIOGEN INC | New Purchase | 3.34% | $153.1M | -34.86% | +8.72% | +53.03% | |
| AVTE - AEROVATE THERAPEUTICS INC | 3.31% | $151.5M | +87.39% | +65.76% | |||
| CTKB - CYTEK BIOSCIENCES INC | Add 39% ($40.7M) | 3.15% | $144.2M | -66.60% | +40.80% | -31.40% | |
| ITOS - ITEOS THERAPEUTICS INC | 3.10% | $142.1M | -45.94% | +23.90% | -19.65% | ||
| TVTX - TRAVERE THERAPEUTICS INC | Reduce 12% $(17.8M) | 2.77% | $126.9M | -38.74% | +15.56% | -28.80% | |
| JANX - JANUX THERAPEUTICS INC | 2.71% | $124.3M | +129.90% | +25.81% | +11.42% | ||
| PCVX - VAXCYTE INC | Add 8% ($8.2M) | 2.41% | $110.6M | +39.20% | +0.16% | +92.72% | |
| ELYM - ELIEM THERAPEUTICS INC | 2.41% | $110.3M | -62.31% | -13.37% | -13.98% | ||
| IMGN - IMMUNOGEN INC | Add 7% ($7.1M) | 2.26% | $103.5M | +45.96% | +251.01% | ||
| DICE - DICE THERAPEUTICS INC | 2.17% | $99.6M | +13.06% | +92.49% | |||
| GHRS - GH RESEARCH PLC | Add 70% ($36.3M) | 1.93% | $88.3M | +22.90% | +16.96% | +7.80% | |
| FMTX - FORMA THERAPEUTICS HLDGS INC | 1.83% | $83.8M | +67.17% | ||||
| TYRA - TYRA BIOSCIENCES INC | 1.69% | $77.4M | +28.57% | +43.87% | +59.92% | ||
| PNT - POINT BIOPHARMA GLOBAL INC | 1.57% | $71.8M | +45.15% | +91.53% | |||
| CLDX - CELLDEX THERAPEUTICS INC NEW | Add 15% ($9.2M) | 1.54% | $70.7M | -35.27% | +21.74% | +6.66% | |
| BLU - BELLUS HEALTH INC NEW | 1.54% | $70.4M | +31.08% | +65.71% | |||
| ENTA - ENANTA PHARMACEUTICALS INC | New Purchase | 1.50% | $68.6M | -85.56% | +39.70% | -48.93% | |
| VOR - VOR BIOPHARMA INC | 1.47% | $67.2M | -94.61% | +22.17% | +8.67% | ||
| NKTX - NKARTA INC | 1.39% | $63.8M | -86.66% | +25.95% | -67.35% | ||
| MRTX - MIRATI THERAPEUTICS INC | Add 93% ($29.0M) | 1.32% | $60.4M | +38.72% | -19.64% | ||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | Add 22% ($10.9M) | 1.31% | $60.1M | -14.20% | +197.16% | +62.84% | |
| RYTM - RHYTHM PHARMACEUTICALS INC | 1.22% | $56.1M | +1911.55% | +634.35% | +400.61% | ||
| ANTX - AN2 THERAPEUTICS INC | New Purchase | 1.21% | $55.3M | -94.09% | +12.19% | -55.93% | |
| RLMD - RELMADA THERAPEUTICS INC | 1.18% | $54.0M | -96.11% | +34.43% | -85.28% | ||
| MGNX - MACROGENICS INC | 1.17% | $53.8M | -65.72% | +6.15% | +44.21% | ||
| NTRA - NATERA INC | New Purchase | 1.16% | $53.3M | +376.42% | +51.32% | +42.89% | |
| TIL - INSTIL BIO INC | 1.14% | $52.4M | -78.34% | -1.29% | -91.41% | ||
| NVAX - NOVAVAX INC | Reduce 67% $(103.5M) | 1.11% | $51.0M | -85.75% | -19.75% | -84.20% | |
| KNTE - KINNATE BIOPHARMA INC | Add 19% ($7.6M) | 1.05% | $48.0M | +44.10% | -60.83% | ||
| VERA - VERA THERAPEUTICS INC | New Purchase | 1.01% | $46.2M | +90.01% | +23.33% | -52.92% | |
| PRDS - PARDES BIOSCIENCES INC | Add 97% ($22.0M) | 0.97% | $44.6M | -50.69% | -67.13% | ||
| ICVX - ICOSAVAX INC | Add 3% ($1.3M) | 0.92% | $42.0M | -1.59% | +9.95% | ||
| TNYA - TENAYA THERAPEUTICS INC | 0.91% | $41.8M | -92.57% | -30.81% | -1.65% | ||
| GERN - GERON CORP | 0.89% | $41.0M | +6.85% | +47.26% | +106.85% | ||
| EYPT - EYEPOINT PHARMACEUTICALS INC | 0.89% | $41.0M | -21.35% | +1.05% | -38.89% | ||
| RNA - AVIDITY BIOSCIENCES INC | New Purchase | 0.87% | $40.0M | +152.77% | +49.50% | -21.80% | |
| ABOS - ACUMEN PHARMACEUTICALS INC | 0.83% | $38.2M | -68.15% | +64.29% | +62.20% | ||
| RXST - RXSIGHT INC | 0.82% | $37.8M | +16.74% | +7.51% | +87.48% | ||
| PMVP - PMV PHARMACEUTICALS INC | 0.78% | $35.6M | -92.76% | +16.16% | -56.94% | ||
| DSGN - DESIGN THERAPEUTICS INC | 0.77% | $35.3M | -67.29% | +90.27% | -44.07% | ||
| RCKT - ROCKET PHARMACEUTICALS INC | 0.73% | $33.4M | -70.69% | +86.67% | +128.15% | ||
| CNTA - CENTESSA PHARMACEUTICALS PLC | 0.70% | $32.1M | +123.77% | -20.00% | -11.89% | ||
| GH - GUARDANT HEALTH INC | New Purchase | 0.69% | $31.6M | +35.03% | +43.43% | -18.97% | |
| ACRS - ACLARIS THERAPEUTICS INC | New Purchase | 0.68% | $31.3M | -86.26% | +45.11% | -26.78% | |
| CCXI - CHEMOCENTRYX INC | New Purchase | 0.63% | $29.0M | +158.29% | |||
| KALV - KALVISTA PHARMACEUTICALS INC | New Purchase | 0.62% | $28.5M | +46.34% | +61.29% | +9.12% | |
| LIAN - LIANBIO | 0.62% | $28.4M | +189.70% | -6.86% | -6.61% | ||
| DYN - DYNE THERAPEUTICS INC | New Purchase | 0.59% | $27.0M | +142.04% | +103.29% | +134.78% | |
| VRNA - VERONA PHARMA PLC | 0.56% | $25.4M | +2127.60% | +213.28% | +405.99% | ||
| IVVD - ADAGIO THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CCCC - C4 THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CNTB - CONNECT BIOPHARMA HLDGS LTD | Reduce 100% | 0.00% | $0.00 | ||||
| CYT - CYTEIR THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| EWTX - EDGEWISE THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | +341.18% | +42.91% | +24.20% | |
| ETNB - 89BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
| GRPH - GRAPHITE BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
| PHAT - PHATHOM PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| TGTX - TG THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | +417.86% | +10.57% | +370.68% | |
| HOWL - WEREWOLF THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| ZGNX - ZOGENIX INC | Reduce 100% | 0.00% | $0.00 | ||||